$RSPI
RespireRx Pharmaceuticals Inc. Stock $rspi

2011 Form 10-K Financial Statement

Concept	2011
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.610M
YoY Change	-46.86%
Cash & Equivalents	$1.610M
Short-Term Investments	$0.00
Other Short-Term Assets	$140.0K
YoY Change	-44.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.740M
YoY Change	-46.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$70.00K
YoY Change	-72.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K
YoY Change	-75.0%
Total Long-Term Assets	$80.00K
YoY Change	-72.41%
TOTAL ASSETS
Total Short-Term Assets	$1.740M
Total Long-Term Assets	$80.00K
Total Assets	$1.820M
YoY Change	-49.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$470.0K
YoY Change	20.51%
Accrued Expenses	$240.0K
YoY Change	-14.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.140M
YoY Change	-1.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change	-100.0%
Total Long-Term Liabilities	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.140M
Total Long-Term Liabilities	$0.00
Total Liabilities	$1.140M
YoY Change	-1.72%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$680.0K
YoY Change
Total Liabilities & Shareholders Equity	$1.820M
YoY Change	-49.02%

Concept	2011
OPERATING ACTIVITIES
Net Income	-$2.250M
YoY Change	-238.04%
Depreciation, Depletion And Amortization	$110.0K
YoY Change	0.0%
Cash From Operating Activities	-$1.940M
YoY Change	-244.78%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$2.030M
YoY Change	-204.1%
Cash From Investing Activities	$2.030M
YoY Change	-201.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	480.0K
YoY Change	-67.35%
NET CHANGE
Cash From Operating Activities	-1.940M
Cash From Investing Activities	2.030M
Cash From Financing Activities	480.0K
Net Change In Cash	570.0K
YoY Change	-29.63%
FREE CASH FLOW
Cash From Operating Activities	-$1.940M
Capital Expenditures	$0.00
Free Cash Flow	-$1.940M
YoY Change	-239.57%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79988864